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ABSTRACT
Aim: The main aim of this study was to determine the prevalence of diabetes mellitus in
patients with active pulmonary tuberculosis at the University of Gondar Teaching
Referral Hospital, northwest Ethiopia.
Study Design: A cross-sectional hospital-based study was performed using the WHO
structured diabetic assessment protocol.
Place and Duration: The study included all active pulmonary tuberculosis patients
visiting the University of Gondar Teaching Referral Hospital during the study period
(October 2011 to November, 2012).
Methodology: We included 199 consecutive active pulmonary tuberculosis patients; 117
of these were male and 108 were urban dwellers. Analyses of fasting blood glucose level
were carried out using blood samples collected by finger puncture. For testing
significance, categorical data were compared using a chi-square test and expressed as
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proportion with a 95% confidence interval.
Result: The prevalence of diabetes was found to be 8.5 % [95%CI: 4.6– 12.5], which
was higher (11.1%) among male than female participants (4.9%). Likewise, 10.2% of the
patients were from urban and 6.6% from rural areas. The proportion of newly diagnosed
diabetic cases was 52.9%, and all of them were between 25-44 years of age. The
Prevalence of impaired fasting glucose was 29.6%. The prevalence of HIV co-infection in
the study population was 28.6% [95%CI: 22.3 34.9] and Diabetes was 4 times higher
among HIV co-infected patients than among HIV-negative tuberculosis patients. Of all
patients with active tuberculosis, 146 (73.7%) were sputum smear negative for acid fast
bacilli. The proportion of diabetes was 9.6% among smear positive and 8.2% among
smear negative cases.
Conclusion: The prevalence of diabetes mellitus and pre-diabetes among active
pulmonary tuberculosis cases was higher compared to the published prevalence of DM
in the general population. Therefore, it is important to implement an active case detection
of diabetes among tuberculosis patients.
.
Keywords: HIV-co infection; IFG; TB-DOTS; TB/DM.
1. INTRODUCTION
Tuberculosis (TB) continues to be the leading killer of the bacterial diseases worldwide. In
2005 there were an estimated 8.8 million new cases of tuberculosis of whom more than 1.7
million died from the disease [1, 2]. According to the 2008 WHO report, Ethiopia ranks
seventh among the world's 22 countries with a high tuberculosis burden [3]. In this
tuberculosis (TB) endemic country, the total number of patients diagnosed to have diabetes
mellitus (DM) is rising. In the year 2000, 2.5% of the Ethiopian people were estimated to
have DM [3].
DM increases the risk for progression from latent TB infection to active TB disease, and
complicates the treatment of active TB as it is hard to treat an infection in the face of poor
glycemic control. A study from the US shows that data from different investigations
consistently reveal that the OR of patients with active TB and DM ranges from 1.3 to 7.8 fold,
indicating that DM clearly increases the risk of TB. Likewise, the number of excess cases of
TB that is attributable to DM has already reached the number of TB cases attributable to HIV
infection [4]. A study showed that the enhanced risk of metabolic syndrome with antiretroviral
drugs could further predispose patients to diabetes, but evidence remains scarce. Long-term
studies are needed to examine the effect of antiretroviral treatment on the rising burden of
diabetes in Ethiopia [5].
WHO suspects that TB control is being undermined by a growing number of DM patients in
the world, which currently stands at an estimated 285 million and is anticipated to reach 438
million by 2030[1, 6]. DM affects lower socioeconomic groups and ethnic minorities with a
higher prevalence of TB.  Hence, TB remains a major cause of mortality in developing
countries, where the prevalence of DM is increasing rapidly. Despite the suggested
significance of DM as a risk factor for TB, little is known about its contribution to the burden
of TB in Ethiopia where both diseases are highly prevalent. [7-9]. Therefore, this study aims
to assess the prevalence of DM and other TB risk factors such as HIV, smoking, and
alcoholism on patients with active pulmonary TB.
British Journal of Medicine & Medical Research, 4(3): 862-872, 2014
864
2. METHODS
This study was conducted at Gondar University Hospital which serves as referral center for
more than 5 million people in the surrounding catchment area. The hospital has DOTS
(Directly Observed Treatment, short course) Follow-up Clinic organized for more about 13
years.
2.1 Study Subjects
This cross-sectional hospital-based study was conducted among patients with active
pulmonary TB aged 15 years and above. All eligible subject with active pulmonary TB cases
who visited the TB-DOTS of the hospital during the data collection period (October 2011 to
August, 2012) were included.
2.2 Sampling
The samples size for the study was determined by assuming the prevalence of DM in
patients with TB to be 15% [10] 80 % power to detect the difference, a 5% level of
significance, and a 10% non-response rate. Accordingly the calculated final sample size of
168 was raised to 199 to increase the statistical power of the sample.
All consecutive subjects with active pulmonary TB who volunteered to participate and signed
a written consent were enrolled.
The diagnosis of pulmonary TB was made according to the national guideline using sputum
smear microscopy for acid fast bacilli (AFB), clinical presentation, and imaging features.
Culture was not available in the hospital. Therefore, culture test was not used for the
diagnosis of TB. Sputum smear positive pulmonary TB was defined when 2 of the three
morning sputum smear tests are positive for AFB or 1 of the 3 are positive with suggestive
CXR and clinical features.
2.3 Screening for DM and HIV
All patients diagnosed as having active pulmonary TB were screened for DM through history,
previous medical records, and measurement of fasting blood glucose (FBG) concentrations.
DM was diagnosed if the FBG concentration was ≥ 126 mg/dL at 2 different time points; FBG
concentrations of 110–125 mg/dl were considered to indicate impaired fasting glucose (IFG),
in accordance with the International Diabetes Federation (IDF) criteria[11]. Blood was
collected from each subject for fasting blood glucose testing. HIV testing was carried out for
all patients with TB according to the hospital routine for provider initiated HIV testing and
counseling practice. Subjects who were tested positive for DM and HIV infected were
referred to the Chronic Illness Clinic for further care and treatment. Prevalence estimations
of diabetes were made for all study subjects, and similar prevalence was determined based
on HIV status, residence (for urban and rural), age, and sex among DM-TB cases directly
from our study data. The prevalence estimation was made along with the 95% confidence
interval (CI).
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2.4 Body Mass Index
Weight and height of study subjects measured using standard measuring equipment at the
DOTS clinic. Body mass index (BMI) calculated by dividing the weight by square of the
height. BMI was used to define underweight (BMI < 18.00 kg/m2), normal (BMI ≥ 18.00 and <
25.00 kg/m2,), overweight and obese (BMI ≥ 25.0 kg/m2) for adults. A structured and
pretested questionnaire was used to collect socio-demographic characteristics, clinical,
laboratory, and chest X-rays (CXR) data.
2.5 Data Analysis
Double data entry procedure was implemented using EPI Info version 3.5.3 and Data
exported to STATA version 11 for analysis. Data were reported as mean and standard
deviation, and crude estimates were calculated using data for TB incidence and DM
prevalence for the study population. For testing significance, categorical data were
compared using a chi-square test and expressed as proportion with a 95% confidence
interval. All significant tests were 2-sided; and the results were considered statistically
significant at P<0.05. Logistic regression was applied to test the presence of association.
Statistical analysis was performed using STATA version 11 software.
3. RESULTS
Of the total 199 active pulmonary TB cases, 117 (58.8%) were male, and 108 (54.3%) of
them were urban dwellers. The mean age (±SD) of the study group was 33.9 (±13.9) ranging
from 14 to 80 years.
Majority of the study subjects were in the age group between 25-44 years. In terms of
occupational status, self-employees and students account for the highest proportion,
131(65.8%) (Table1).
The prevalence of DM was 8.5% [95%CI: 4.6, 12.5] among patients with pulmonary TB and
all of them were in age group 25-44 years. The prevalence of DM among the male was 11.1
% [95%CI: 5.3, 16.9], and among the female 4.9% [95% CI: .2, 9.04].  Likewise, 10.2% [4.4,
15.9] of the participants were from urban areas, and 6.6% [95%CI: 1.4, 11.8] from rural
settings (Table 3). Newly diagnosed DM account for nearly 53% of all patients tested
positive for DM.
The prevalence of IFG among patients with active pulmonary TB was 29.6% [95%CI: 23.2,
36.0]; which was slightly higher in subjects from rural residence (34.1%) [95%CI: 24.2, 43.9]
compared with those from urban areas 25.9% [95%CI: 17.6, 34.3]. The Prevalence of IFG
was 31.7% [95%CI: 21.5, 41.9] among women and 28.2% [95%CI: 19.9 – 36.4] among men
(Fig. 1).
HIV co-infection rate among the study population of active pulmonary TB cases was 28.6%
[95%CI: 22.3, 34.9]. The proportion was 32.9% [95%CI: 22.6, 43.2] in women and 25.6%
[95%CI: 17.6, 33.6] in men. HIV co-infection   was higher (40.7%) in subjects from urban
areas than in those from rural settings (14.3%). The occurrence of DM in HIV co-infected
study subjects was 4 times higher than HIV-negative TB patients (OR 4.1, P= .004). The
proportion of cigarette smokers was 3% and that of alcohol consumers was 4.6%. About 47
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% of the study subjects were under weight, 50.3% normal weight, and 2.03 % overweight
and/or obese Table 2.
The majority (72.5%) of the TB patients had TB symptoms for more than 3 weeks, and only
3.6 % for a week. Delayed diagnosis of pulmonary TB was observed among rural residents,
and the difference was statistically significant (p=.001).
Of the study subjects, 147 (73.9%) were sputum smear negative for AFB at baseline, and
DM was higher in smear positive subjects (9.6%) than smear negative (8.2%). Chest
radiographic study was available for a number of patients at base line and among these
73.7% showed typical post-primary radiographic picture, .6% primary, 22.8% atypical, and
3% normal (Table 2).
Table 1. Distribution of socio-demographic variable by residence and sex at Gondar
university hospital, North West Ethiopia, 2012
Characteristics Urban Rural Total n (%)
Male n (%) Female n (%) Male n (%) Female n (%)
Age
≤ 24
25-44
45-64
≥ 65
24 (36.9%)
31 (47.7%)
6 (9.2%)
4 (6.2%)
15 (34.9%)
21 (48.8%)
6 (13.9%)
1 (2.3%)
15 (28.9%)
23 (44.2%)
10 (19.2%)
4 (7.7%)
7 (17.9%)
20 (51.3%)
11 (28.2%)
1 (2.6%)
61 (30.7%)
95 (47.7%)
33 (16.6%)
10 (5.03%)
Total 65 (32.7%) 43 (21.6%) 52 (26.1%) 39 (19.6%) 199
Education
No formal schooling
Grade 1-6
Grade7-12+1
Diploma and above
18 (28.6%)
3 (4.8%)
18 (28.6%)
24 (38.1%)
11(26.8%)
5 (12.2%)
15 (36.6%)
10 (24.4%)
36 (72%)
2 (4%)
6 (12%)
6 (12%)
35 (89.7%)
1 (2.6%)
2 (5.1%)
1 (2.6%)
100 (51.8%)
11 (5.7%)
41 (21.2%)
41 (21.2%)
Total 63 (32.6%) 41 (21.2%) 50 (25.9%) 39 (20.2%) 193
Marital Status
Never married
Currently married
Separated
Widowed
42 (64.6%)
20 (30.8%)
3 (4.6%)
0 (0.0%)
19 (44.2%)
9 (20.9%)
10 (23.3%)
5 (11.6%)
23 (44.2%)
22 (42.3%)
7 (13.5%)
0 (0.0%)
5 (12.8%)
26 (66.7%)
3 (7.7%)
5 (12.8%)
89 (44.7%)
77 (38.7%)
23 (12%)
10 (5.03%)
Total 65 (32.7%) 43 (21.6%) 52 (26.1%) 39 (19.6) 199
Occupational
Gov employed
self employed
Student
Homemaker
Retire
Un-employed
11 (16.9%)
27 (41.5%)
23 (35.4%)
0 (0.0%)
0 (0.0%)
4 (6.1%)
4 (9.3%)
12 (27.9%)
10 (23.3%)
14 (32.6%)
0 (0.00%)
3 (6.9%)
0 (0.0%)
40 (76.9%)
9 (17.3%)
1(1.9%)
1 (1.9%)
1 (1.9%)
0 (0.0%)
8 (20.1%)
2 (5.1%)
27 (69.2%)
0 (0.0%) 2
(5.1%)
15 (7.5%)
87 (43.7%)
44 (22.1%)
42 (21.1%)
1 (.5%)
10 (5.1%)
Total 65 (32.7%) 43 (21.6%) 52 (26.1%) 39 (19.6) 199
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Table 2. Health related characteristics of the study group distributions by sex at
Gondar University hospital, Northwest Ethiopia, 2012
Characteristics Total n (%) Male n (%) Female n (%)
FBG level
70-109
110-125
≥ 126
123 (61.8)
59 (29.7)
17 (8.5)
71 (57.7)
33 (55.9)
13 (76.5)
52 (42.3)
26 (44.1)
4 (23.5)
Total 199 117 (59.1) 82 (40.9)
HIV/AIDS  status
HIV Positive
HIV Negative
Total
57 (28.4)
142 (71.4)
199
30 (52.6)
87 (61.3)
117 (59.2)
27 (47.4)
55 (38.7)
82 (40.8)
Smoking
Yes
No
6 (3.0)
192 (96.9)
6  (100)
111 (57.5)
0 (.00)
82 (42.5)
Total 198 117 (59.1) 81 (40.9)
Drinking Alcohol
Yes
No
9 (4.6%)
190 (95.5)
9 (100)
108 (56.8)
0 (.00)
81 (43.2)
Total 199 117 (59.1) 81 (40.9)
BMI (kg/m2)
< 18
18-24.9
25 and above
96 (48.2)
99 (49.8)
4 (2.0)
55 (57.3)
60 (60.6)
2 (50.0)
41 (42.7)
39 (39.4)
2 (50.0)
Total 199 117 (59.2) 81 (40.8)
Waist circumference
<90
≥ 90
194 (97.5)
5(2.5)
114 (58.7)
3 (60.0)
80 (41.2)
2 (40.0)
Total 199 117(59.3) 82 (40.7)
Duration of TB Symptom
≤ 1
2-3 weeks
> 3 week
9 (4.5)
48 (24.1)
142 (71.4)
4 (44.4)
34 (70.8)
79 (55.6)
5 (55.6)
14 (29.2)
63 (44.4)
Total 199 117 (60.1) 82 (39.9)
Sputum smear test for AFB
Positive
Negative
52 (26.1)
147 (73.9)
30 (57.7)
87 (59.2)
22 (42.3)
60 (40.8)
Total 199 117 (58.8) 82(41.2)
Chest x-ray (CXR)
Typical post prim
Primary
Atypical
Normal
No CXR
124 (62.3)
1 (.5)
38 (19.1)
5 (2.5)
31 (15.6)
72 (58.1)
1 (1.1)
18 (47.4)
2 (2.15)
24 (77.4)
52 (41.9)
0 (.00)
20 (52.6)
3 (4.0 )
7 (22.6)
Total 199 117 (55.7) 82 (41.2)
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Table 3. Socio-demographic characteristics and HIV status of study subjects with
diabetes Mellitus in active pulmonary TB at Gondar referral Hospital of Gondar, North
West Ethiopia (2013)
Variable N (%) Diabetic cases # (%)
Age in year
≤ 24
25-44
45-64
≥65
61 (30.8)
94 (47.5)
33 (16.7)
0 (0.00)
0 (0.00)
13 (13.8)
4 (12.1)
0 (0.00)
Sex
Male
Female
117 (58.8)
82 (41.2)
13 (11,1)
4 (4.9)
Residence
Urban
Rural
108 (54.3)
91 (45.7)
11 (10.2)
6 (6.6)
HIV Status
HIV positive
HIV Negative
57 (28.6)
142 (71.4)
10 (17.5)
7 (4.9)
Education
No formal schooling
Grade 1-12
Diploma and above
100( 51.8)
52 (26.9)
41 (21.2)
9 (9.00)
3 (7.3)
2 (4.9)
Marital Status
Never married
Currently married
Separated
89 (44.7)
77 (38.7)
33 (16.6)
3 (3.4)
9 (11.7)
5 (15.2)
Fig. 1. Prevalence of diabetes mellitus and impaired fasting glucose by sex and HIV
status among pulmonary active tuberculosis patient in Gondar University Referral
Hospital, North West Ethiopia, 2012
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4. DISCUSSION
In this institution-based cross- sectional study, we have found that the prevalence of DM was
higher among patients with active pulmonary TB, which is almost three times higher than the
estimated population prevalence of DM in Ethiopia [12]. Our finding is in line with reports of
high prevalence from Mexico (25%), Tanzania (16.7%), India (14.8% - 44%), Indonesia
(13.2%), Pakistan (9.5%), and China (12.4%) [1,13-16]. The wide range of prevalence of DM
in different studies might be due to the socio-demographic characteristics of source
populations in the localities studied.  Previous literature supports that DM is an important risk
factor for the occurrence of TB. [12,13,17].
The higher prevalence of DM among patients with TB was associated with male study
subjects, urban dwellers, and HIV co-infected ones. The high prevalence of DM in the males
was very close to the findings in Pakistan and India [13,18,19]. On the other hand, the
prevalence of DM in urban areas was also comparable to that of other studies [1,18-20]. The
observed rise in the prevalence of DM in urban areas can be explained by rapid
urbanization, overcrowded living conditions and the high HIV co-infection rate in the study
areas [21].
This study also demonstrated that significant proportion of new cases of DM (50%) was
detected by doing active screening for DM in patients with pulmonary TB. A similar study
conducted in Kerala, India, showed a high prevalence of undiagnosed DM among new
pulmonary TB cases. This high proportion of undiagnosed cases may indicate less
awareness of DM by the public and lack of access to health care services for the diagnosis
of DM [20,22]. This finding call for the implementation of active case finding of DM in patients
diagnosed for TB and the integrating of TB and DM care programs. Similarly, the overall
proportion of IFG among newly diagnosed pulmonary TB cases was higher than the report
from Indonesia (3.7%), India (24.5%) and Guinea (31%) [14,18,23] and lower than that of a
study done in Tanzania 37.6% [15].
The proportion of DM among HIV co-infected active pulmonary TB cases was high. In
agreement with this finding, other studies showed that the prevalence  of tuberculosis cases
to become diabetic was 4 times higher among HIV co-infected patients compared with HIV-
negative tuberculosis patients [15]. The huge prevalence of DM in HIV patients can
contribute to the increasing prevalence of active pulmonary tuberculosis.
We found a high prevalence of DM amongst younger TB patients (25- 44 years of age), and
more proportion of DM was found among the smear positive cases. In line with this finding, a
study performed among non-North Americans and Europeans showed higher risk among
younger people, with a high background of TB incidence [10,12,20]. The rising prevalence of
DM/ TB burden in this group will adversely affect TB control programs and will become
another burden to the health system.
This study contributes to the growing body of evidence on the importance of the TB/DM
relationship. To our information, this is among the very few investigations that assessed the
association between DM and TB in Ethiopia. The findings we report indicate that diabetes
was high among tuberculosis patients. Since TB patients with DM have an increased risk of
poor treatment out-come, it is important to launch a well-functioning chronic disease and TB
control programs in countries like Ethiopia where the prevalence of HIV and TB epidemic is
high.
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5. CONCLUSION
The prevalence of diabetes mellitus and pre-diabetes among active pulmonary tuberculosis
cases was higher compared to the published prevalence of DM in the general population at
Gondar University Referral Hospital, and more than half of the DM cases were undiagnosed
before the time of screening. Furthermore, the proportion of DM among HIV co-infected
patients of newly diagnosed pulmonary TB cases was very high. Therefore, it is imperative
to have active case detection of DM in patients with TB and active case detection of TB in
patients with DM.
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